Sage for Health & Longevity - Quick Reference Sheet

Sage for Health & Longevity

Created on 07/14/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Sage's concentrated leaf extracts show modest promise beyond the kitchen. A single dose can sharpen memory, attention, and mood within an hour; longer courses may lower blood sugar and cholesterol and ease menopausal hot flashes. Its essential oil can trigger seizures at high doses. Inexpensive and generally well tolerated, but human evidence remains thin. (Full Review)

Protocol

Form
Standardized leaf extract
Aqueous or hydroethanolic leaf, dried leaf, or tea; avoid internal essential oil
Dose
500 mg, 3× daily (metabolic)
300–600 mg dried leaf or 167–333 mg extract as a single dose for cognition
Timing
Morning or with meals
Morning single dose for cognition; with meals for glucose and lipids
Time to effect
Cognition & Mood
~1 hour
Single dose; lasts several hours
Glucose & Lipids
4 weeks–3 months
Metabolic trial endpoints
Hot Flashes
4–8 weeks
Reduced frequency in menopausal women

Benefits

Contraindications
  • Pregnancy
  • Breastfeeding (unless intentionally weaning)
  • Epilepsy or seizure disorder (especially essential oil)
  • Hormone-sensitive cancers
  • Uncontrolled hypoglycemia risk on insulin or sulfonylureas
  • Surgery within two weeks
Key Interactions
  • Antidiabetic drugs (insulin, sulfonylureas, metformin)
  • Antihypertensive drugs (ACE inhibitors, calcium-channel blockers, diuretics)
  • Cholinergic & anticholinergic drugs (donepezil, rivastigmine, oxybutynin)
  • Anticoagulants & antiplatelets (warfarin, aspirin, clopidogrel)
  • Sedatives & CNS depressants (benzodiazepines, alcohol)
  • Hormonal therapies (tamoxifen, aromatase inhibitors, hormone replacement therapy)
  • Iron supplements

Risk & Side Effects

  • High: Thujone-related neurotoxicity & seizure risk
  • Medium: Additive hypoglycemia with antidiabetic therapy; reduced milk supply
  • Low: Mild hypotension; gastrointestinal upset, dry mouth & oral irritation; estrogenic effects in hormone-sensitive conditions
  • Speculative: Hepatotoxicity at very high or prolonged doses; pregnancy-related risks

Monitoring

Marker Target Why
Fasting blood glucose 70–85 mg/dL Tracks sage's glucose-lowering effect and guards against hypoglycemia
HbA1c (glycated hemoglobin) < 5.4% Reflects average blood sugar over ~3 months
Fasting lipid panel (LDL, HDL, TG, total) LDL < 100 (optimal < 80); HDL > 60; TG < 100 mg/dL Tracks sage's cholesterol- and triglyceride-lowering effect
Liver enzymes (ALT, AST) ALT < 25 (women) / < 30 (men) U/L Safety check for the theoretical hepatic risk of high-dose or prolonged use
Blood pressure < 120/80 mmHg Detects the mild additive hypotension seen with sage

Cadence: Baseline, then glucose and lipids at 4–8 weeks and 3 months, then every 6–12 months if continued; liver enzymes at 3 months if high-dose or prolonged; monitor glucose more frequently in the first 2–4 weeks when combined with antidiabetic therapy.

Qualitative Assessment

  • Memory and recall (subjective sharpness, word-finding, name recall)
  • Attention, focus, and speed of mental processing
  • Mental fatigue and daytime alertness, especially during demanding tasks
  • Mood, calmness, and anxiety levels
  • Hot-flash frequency and severity (for menopausal users)
  • Digestive comfort and any dry mouth or oral irritation as tolerability signals